Prognostic impact of Thomsen–Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients
✍ Scribed by Christian Schindlbeck; Udo Jeschke; Sandra Schulze; Uwe Karsten; Wolfgang Janni; Brigitte Rack; Stan Krajewski; Harald Sommer; Klaus Friese
- Publisher
- Springer US
- Year
- 2006
- Tongue
- English
- Weight
- 166 KB
- Volume
- 101
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Adjuvant chemotherapy is not routinely recommended in patients with colorectal cancer stage UICC II. Some of these patients, however, develop recurrent disease. Therefore, valid prognostic criteria are needed to identify high‐risk patients who might benefit from adjuvant therapy. Dissem
## Abstract The present study aimed to investigate the clinical relevance of disseminated tumor cells (DTC) in breast cancer patients before and after high‐dose adjuvant chemotherapy with or without progenitor stem‐cell support. One hundred and eighteen high‐risk stage II breast cancer patients ent